Inmune Bio (INMB) Price to Sales (2021 - 2025)
Inmune Bio's Price to Sales came in at 829.46 for Q4 2025, down 88.8% from 7432.12 a year earlier and down 24.6% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Price to Sales (2021 - 2025) Analysis & Trends
Going back to Q1 2021, Inmune Bio's Price to Sales data covers 20 quarters.
- Going back by year, Price to Sales was 7432.12 in FY2024 (+469.9%), 1304.04 in FY2023 (+328.7%), 304.22 in FY2022 (-69.7%) and 1005.53 in FY2021 (-95.2%).
- The Q4 2025 figure represents the lowest quarterly Price to Sales since Q3 2023.
- Year-over-year, Price to Sales has declined for three consecutive quarters, with growth averaging 165.4% over the last eight quarters.
- The fastest year-over-year change in Price to Sales over five years came in Q4 2024 (growth of 469.9%), and the weakest in Q2 2022 (a decline of 99.3%).
- Business Quant data shows INMB's Price to Sales at 1100.63 (Q3 2025), 1228.24 (Q2 2025) and 3581.73 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Inmune Bio | 53.37 Mn | -38.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 829.46 |
| Sep 30, 2025 | 1,100.63 |
| Jun 30, 2025 | 1,228.24 |
| Mar 31, 2025 | 3,581.73 |
| Dec 31, 2024 | 7,432.12 |
| Sep 30, 2024 | 2,845.46 |
| Jun 30, 2024 | 2,044.86 |
| Mar 31, 2024 | 1,610.09 |
| Dec 31, 2023 | 1,304.04 |
| Sep 30, 2023 | 542.39 |
| Jun 30, 2023 | 584.05 |
| Mar 31, 2023 | 465.59 |
| Dec 31, 2022 | 304.22 |
| Sep 30, 2022 | 252.88 |
| Jun 30, 2022 | 445.63 |
| Mar 31, 2022 | 444.43 |
| Dec 31, 2021 | 1,005.53 |
| Sep 30, 2021 | 19,250.94 |
| Jun 30, 2021 | 66,437.31 |
| Mar 31, 2021 | 44,349.94 |
API Access
Inmune Bio Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();